RGN-137
Broad Categorization
Inflammatory Disease
Indication
Wound healing (Epidermolysis bullosa, Pressure ulcers, Venous stasis ulcers)
Licensee
RegeneRX Biopharmaceuticals
Phase
Phase II
Product Type
RGN-137